Biosante to get $25.

Biosante to get $25 sexual relationship read more .1 million shares of common stock in registered direct offering BioSante Pharmaceuticals, Inc. today announced that it offers received commitments from many institutional investors to get $25.1 million of securities in a registered direct offering. BioSante expects to get net proceeds of around $23.8 million after deducting positioning agent fees and other offering expenses. BioSante provides entered into securities buy agreements with these traders pursuant to which BioSante provides agreed to offer an aggregate of around 12.2 million shares of its common stock and warrants to get up to approximately 4.0 million extra shares of its common stock.